Insider Transactions in Q4 2022 at Eli Lilly & CO (LLY)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 19
2022
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
32
+0.06%
|
$11,424
$357.78 P/Share
|
|
Dec 19
2022
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
28
+0.04%
|
$9,996
$357.78 P/Share
|
|
Dec 19
2022
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
28
+4.72%
|
$9,996
$357.78 P/Share
|
|
Dec 19
2022
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
27
+1.36%
|
$9,639
$357.78 P/Share
|
|
Dec 19
2022
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
39
+0.26%
|
$13,923
$357.78 P/Share
|
|
Dec 19
2022
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
28
+1.74%
|
$9,996
$357.78 P/Share
|
|
Dec 02
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
49,089
-0.01%
|
$18,261,108
$372.97 P/Share
|
|
Dec 01
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
160,911
-0.03%
|
$60,019,803
$373.31 P/Share
|
|
Nov 21
2022
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
525
+0.37%
|
$189,525
$361.17 P/Share
|
|
Nov 21
2022
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
359
+24.97%
|
$129,599
$361.17 P/Share
|
|
Nov 21
2022
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
498
+8.28%
|
$179,778
$361.17 P/Share
|
|
Nov 21
2022
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
525
+11.22%
|
$189,525
$361.17 P/Share
|
|
Nov 21
2022
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
537
+1.78%
|
$193,857
$361.17 P/Share
|
|
Nov 21
2022
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
525
+13.38%
|
$189,525
$361.17 P/Share
|
|
Nov 21
2022
|
Katherine Baicker Director |
BUY
Grant, award, or other acquisition
|
Direct |
498
+2.2%
|
$179,778
$361.17 P/Share
|
|
Nov 21
2022
|
Jamere Jackson Director |
BUY
Grant, award, or other acquisition
|
Direct |
498
+5.62%
|
$179,778
$361.17 P/Share
|
|
Nov 21
2022
|
William G Kaelin Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
498
+2.38%
|
$179,778
$361.17 P/Share
|
|
Nov 21
2022
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
498
+0.78%
|
$179,778
$361.17 P/Share
|
|
Nov 21
2022
|
Marschall S Runge Director |
BUY
Grant, award, or other acquisition
|
Direct |
498
+3.0%
|
$179,778
$361.17 P/Share
|
|
Nov 21
2022
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
529
+0.5%
|
$190,969
$361.17 P/Share
|
|
Nov 07
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
63,585
-0.01%
|
$23,144,940
$364.42 P/Share
|
|
Nov 04
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
1,336
-0.0%
|
$484,968
$363.73 P/Share
|
|
Nov 03
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
133,948
-0.13%
|
$48,489,176
$362.08 P/Share
|
|
Nov 02
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
6,131
-0.01%
|
$2,219,422
$362.07 P/Share
|
|
Oct 21
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
161,936
-0.02%
|
$54,734,368
$338.9 P/Share
|
|
Oct 19
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
3,547
-0.0%
|
$1,188,245
$335.48 P/Share
|
|
Oct 18
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
12,042
-0.01%
|
$4,022,028
$334.29 P/Share
|
|
Oct 17
2022
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
30
+2.83%
|
$9,960
$332.76 P/Share
|
|
Oct 17
2022
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
42
+0.3%
|
$13,944
$332.76 P/Share
|
|
Oct 17
2022
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
29
+2.03%
|
$9,628
$332.76 P/Share
|
|
Oct 17
2022
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
30
+14.49%
|
$9,960
$332.76 P/Share
|
|
Oct 17
2022
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
30
+0.04%
|
$9,960
$332.76 P/Share
|
|
Oct 17
2022
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
34
+0.07%
|
$11,288
$332.76 P/Share
|
|
Oct 17
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
79,624
-0.02%
|
$26,674,040
$335.88 P/Share
|
|
Oct 14
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
3,187
-0.0%
|
$1,064,458
$334.41 P/Share
|
|
Oct 12
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
400
-0.0%
|
$133,200
$333.5 P/Share
|
|
Oct 10
2022
|
Alonzo Weems EVP, ERM & CECO |
SELL
Bona fide gift
|
Direct |
450
-6.47%
|
-
|
|
Oct 10
2022
|
Alonzo Weems EVP, ERM & CECO |
SELL
Open market or private sale
|
Direct |
656
-8.62%
|
$213,856
$326.23 P/Share
|
|
Oct 06
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
149,264
-0.02%
|
$50,152,704
$336.56 P/Share
|